Pharmaceuticals
Company Overview of Lev Pharmaceuticals, Inc.
Company Overview
As of October 21, 2008, Lev Pharmaceuticals, Inc. was acquired by ViroPharma Inc. Lev Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on developing and commercializing therapeutic products for the treatment of inflammatory diseases. Its products include C1-INH that is used for the treatment of hereditary angioedema. The company was founded in 2003 and is based in New York, New York.
122 West 42nd Street
New York, NY 10168
United States
Founded in 2003
27 Employees
Phone:
212-682-3096
Key Executives for Lev Pharmaceuticals, Inc.
Lev Pharmaceuticals, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
| Company Name | Region |
| Minerva Biotechnologies Corporation | United States |
| Schiff & Company, Inc. | United States |
| IBC Pharmaceuticals, L.L.C. | United States |
| Genentech, Inc. | United States |
| Lycera Corporation | United States |
Recent Private Companies Transactions
| Type Date |
Target | |
| No transactions available in the past 12 months. | ||
Most Searched Private Companies
| Company Name | Geographic Region |
| Bertelsmann AG | Europe |
| Lawyers Committee for Civil Rights Under Law | United States |
| NYC2012, Inc. | United States |
| Rush University | United States |
| Citizens Budget Commission | United States |
Post a JobJobs
- Field, KY | Shire PharmaceuticalsPosted: May 26
- Chapel Hill, NC | Cempra PharmaceuticalsPosted: Jun 11
- Field, KY | Shire PharmaceuticalsPosted: May 26
- Field, KY | Shire PharmaceuticalsPosted: May 09
Sponsored Financial Commentaries
Sponsored Links
To contact Lev Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
